Aegis Awarded Its First Patent for Non-Invasive Delivery of a Protein Drug to the Central Nervous System (CNS)

barbara.lempert SAN DIEGO, CA October 9, 2013/MarketWired– Aegis Therapeutics LLC announced today that it has been awarded its first patent for non-invasive delivery of a protein ...

First Patient Enrolled in Phase III Trial Evaluating The Medicines Company’s Angiomax

barbara.lempert First Patient Enrolled in Phase III Trial Evaluating The Medicines Company’s Angiomax(R) (Bivalirudin) in Patients Undergoing Peripheral Endovascular ...

Adocia: Activity and results for the first half of 2013

barbara.lempert Intensification of R&D activity ahead of the launch of three clinical trials for insulin projects, starting in the second half of 2013 Net result of EUR -4.6 million ...

Amorfix Announces Fiscal 2014 First Quarter Results

barbara.lempert TORONTO, Aug. 13, 2013 /CNW/ – Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today ...

Novartis Becomes First Company to Earn CEO Cancer Gold Standard

mia.burns Novartis first company accredited with global “CEO Cancer Gold Standard” for outstanding efforts in cancer prevention and treatment   The non-profit ...

Trophos completes patient enrolment in a first study of olesoxime in relapsing remitting Multiple Sclerosis

barbara.lempert Topline results for olesoxime as add–on therapy to Interferon beta are expected in early 2014   Marseille, France, August 6, 2013 – Trophos SA, a clinical ...

IMRIS Obtains CE Mark for First Ceiling-Mounted Intraoperative CT Solution

barbara.lempert VISIUS iCT expands state-of-the-art surgical theater imaging into European market WINNIPEG, MB and MINNEAPOLIS, MN, Aug. 5, 2013 /CNW/ – IMRIS Inc. (NASDAQ: ...

Omeros eyes first approval for combo eye drug; MorphoSys plans jump into immunotherapy work;

John Carroll FierceBiotech News

Aeterna Zentaris: First Patient Dosed for Phase 3 Registration Trial in Endometrial Cancer with Zoptarelin Doxorubicin

barbara.lempert Aeterna Zentaris: First Patient Dosed for Phase 3 Registration Trial in Endometrial Cancer with Zoptarelin Doxorubicin (AEZS-108) All amounts are in U.S. dollars (unless ...

Sanofi Pasteur Announces Shipment of First Lots of 2013-2014 Seasonal Influenza Vaccine in U.S.

barbara.lempert – Largest supplier of influenza vaccine in U.S., first to ship, will distribute more than 60 million doses of flu vaccines for fall immunization campaigns – ...

Roche First Half Net Up 10%

barbara.lempert Roche posts strong first-half results Group sales 5%1 higher at 23.3 billion Swiss francs Core EPS 12% higher at 7.58 Swiss francs; net income rose to ...

Galectin Therapeutics Doses First Patient in GR-MD-02 Trial

mia.burns Galectin Therapeutics Announces First Patient Dosed in Phase 1 Trial of GR-MD-02, a Potential First-in-Class Treatment for Fatty Liver Disease with Advanced Fibrosis   Norcross, ...
Page 3 of 712345...Last »
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS